MCRB SERES THERAPEUTICS INC Disposals and divestitures 8-K Filing 2024 - Business Sale Approved Seres Therapeutics' stockholders approved the sale of its VOWST microbiome therapeutic business to Nestlé's subsidiary, with 77 million votes in favor and 7 million against, during a special meeting held on September 26, 2024.Get access to all SEC 8-K filings of the SERES THERAPEUTICS INC